natgillin/translations-raw huggingface dataset:
gastrointestinal motility disorders including untreated or severe gastroparesis, diverticulosis retention of gastric contents and abnormal or irregular bowel motion patients with a history of major gastrointestinal surgery
gastrointestinalnimi motnjami, vključno z nezdravljeno ali hudo gastroparezo, divertikulozo, zastajanjem hrane v želodcu in nenormalnim ali nepravilnim gibanjem črevesja pri bolnikih, ki so imeli v preteklosti obsežno gastrointestinalno operacijo.
gastrointestinal motility disorders including untreated or severe gastroparesis, diverticulosis, retention of gastric contents and abnormal or irregular bowel motion patients with a history of major gastrointestinal surgery
gastrointestinalnimi motnjami, vključno z nezdravljeno ali hudo gastroparezo, divertikulozo in zastajanjem hrane v želodcu in nenormalnim ali nepravilnim gibanjem črevesja pri bolnikih, ki so imeli v preteklosti obsežno gastrointestinalno operacijo
Gastrointestinal neoplasia including hepatobiliary tract
Novotvorbe prebavil, vključno z jetri, žolčnikom in žolčevodi
Gastrointestinal obstruction
Obstrukcija prebavil
gastrointestinal obstructions (blockages of the digestive system).
obstrukcija prebavne poti (zapora prebavnega sistema)
Gastrointestinal obstructive disorders (e.g. pyloric stenosis)
z gastrointestinalnimi obstruktivnimi motnjami (npr. pilorična stenoza);
Gastrointestinal pain
gastrointestinalna bolečina
Gastrointestinal perforation
perforacija prebavil
Gastrointestinal perforation
Perforacija v prebavilih
Gastrointestinal perforation (Gastrointestinal perforation, Intestinal perforation, Large intestine perforation).
perforacija v prebavilih (perforacija v prebavilih, perforacija črevesa, perforacija debelega črevesa)
Gastrointestinal perforation (including fatal outcome) and fistulae have been reported in patients treated with Stivarga (see section 4.8).
Pri bolnikih, zdravljenih z zdravilom Stivarga, so poročali o gastrointestinalni perforaciji (vključno s smrtnim izidom) in fistuli (glejte poglavje 4.8).
Gastrointestinal perforation and fistula formation (see section 4.4)
Perforacija prebavil in nastanek fistule (glejte poglavje 4.4)
Gastrointestinal perforation and fistulac,k
perforacija prebavil in fistula c, k
Gastrointestinal perforation in some cases leading to death has been observed in patients receiving MabThera for treatment of non-Hodgkgin lymphoma.
Perforacijo prebavil, ki je v nekaterih primerih povzročila smrt, so opazili pri bolnikih, ki so prejemali zdravilo MabThera za zdravljenje ne-Hodgkinovega limfoma.
Gastrointestinal perforation in some cases leading to death has been observed in patients receiving MabThera for treatment of Non-Hodgkin’s lymphoma (NHL).
Perforacijo prebavil, ki je v nekaterih primerih povzročila smrt, so opazili pri bolnikih, ki so prejemali zdravilo MabThera za zdravljenje ne-Hodgkinovega limfoma.
Gastrointestinal perforation* Gastrointestinal fistula
gastrointestinal-na perforacija* gastrointestinal-na fistula
Gastrointestinal perforation, oesophagitis, gastrointestinal infection, ileus, gastrointestinal obstruction, ascites, lip oedema, oesophageal spasm, gastric ulcer, gastroesophageal reflux disease, reflux gastritis, retroperitoneal fibrosis, gastrointestinal disorder, anal haemorrhage, haemorrhoids, salivary hypersecretion, retching, salivary gland disorder, cheilitis, aerophagia, eructation, glossodynia, oral pain, teeth brittle
gastrointestinalna perforacija, ezofagitis, gastrointestinalna okužba, ileus, gastrointestinalna obstrukcija, ascites, edem ustnic, ezofagealni spazem, želodčna razjeda, gastroezofagealna refluksna bolezen, refluksni gastritis, retroperitonealna fibroza, prebavne motnje, analna krvavitev, hemoroidi, povečano izločanje sline, draženje na bruhanje, delovanja žlez slinavk, heilitis, aerofagija, spahovanje, glosodinija, bolečina v ustih, motnje krhkost zob
Gastrointestinal perforation.
Gastrointestinalna perforacija
Gastrointestinal perforation1, acute pancreatitis1
perforacija prebavil1, aktuni pankreatitis1
Gastrointestinal perforation1, acute pancreatitis1
perforacija prebavil1, akutni pankreatitis1
Gastrointestinal perforationl (<1%)
perforacija v prebavilih1 (< 1 %)
Gastrointestinal perforations
Predrtje prebavil
Gastrointestinal perforations (see section 4.4).
perforacije prebavil (glejte poglavje 4.4),
Gastrointestinal perforations and fistula
Perforacije in fistula v gastrointestinalnem traktu
Gastrointestinal perforations have been observed (uncommon: may affect up to 1 in 100 people).
Opazili so predrtja v prebavilih (občasno: pojavi se lahko pri največ 1 od 100 bolnikov).
Gastrointestinal perforations have been reported in clinical trials with an incidence of less than 1% in patients with non-squamous non-small cell lung cancer, up to 1.3% in patients with metastatic breast cancer, up to 2.0% in patients with metastatic renal cell cancer or in patients with ovarian cancer receiving front-line treatment, and up to 2.7% (including gastrointestinal fistula and abscess) in patients with metastatic colorectal cancer.
O perforacijah prebavil so v kliničnih preskušanjih pri bolnikih z neskvamoznim nedrobnoceličnim rakom pljuč poročali z incidenco, manjšo od 1 %, pri bolnikih z metastatskim rakom dojk z incidenco do 1,3 %, pri bolnikih z metastatskim rakom ledvičnih celic ali pri bolnicah z rakom jajčnikov, ki so prejele prvo zdravljenje, z incidenco do 2,0 % ter pri bolnikih z metastatskim rakom debelega črevesa in danke do 2,7 % (vključno z gastrointestinalno fistulo in abscesom).
GASTROINTESTINAL PRODUCTS
ZDRAVILA Z DELOVANJEM NA PREBAVILA
GASTROINTESTINAL PRODUCTS (PROPULSIVE)
ZDRAVILA Z DELOVANJEM V PREBAVILIH (PROPULZIVI)
Gastrointestinal reactions contributed to the reasons for early discontinuation from the trial for 4 (14%) patients.
Neželeni učinki na prebavila so povzročili prezgodnjo prekinitev preskušanja pri 4 (14 %) bolnikih.
Gastrointestinal reactions such as nausea and vomiting as well as loss of appetite.
Prebavne reakcije, npr. slabost v želodcu in bruhanje, pa tudi izguba apetita.
Gastrointestinal reactions such as nausea and vomiting as well as loss of appetite.
reakcije prebavil, na primer slabost s siljenjem na bruhanje (navzea) in bruhanje, pa tudi izguba teka,
Gastrointestinal signs and symptoms (abdominal pain, nausea, vomiting, diarrhoea, flatulence)
znaki in simptomi v prebavilih (kot so trebušne bolečine, siljenje na bruhanje, bruhanje, driska, vetrovi)
gastrointestinal stenosis (narrowing of part of the digestive system).
tenoza prebavne cevi (zožitev dela prebavil)
Gastrointestinal stoma complication*
zapleti v zvezi z gastrointestinalno stomo
Gastrointestinal stromal tumour (GIST)
Gastrointestinalni stromalni tumor (GIST – gastrointestinal stromal tumour)
gastrointestinal stromal tumour (GIST), a type of cancer of the stomach and bowel where there is uncontrolled growth of cells in the supporting tissues of these organs.
gastrointestinalnega stromalnega tumorja (GIST), tj. vrste raka želodca in črevesja, pri katerem celice v opornem tkivu teh organov nenadzorovano rastejo.
Gastrointestinal stromal tumour (GIST), a type of cancer of the stomach and bowel, where imatinib (another anticancer medicine) no longer works or you cannot take imatinib.
Gastrointestinalni stromalni tumor (GIST), vrsta raka na želodcu in črevesju, kjer zdravljenje z imatinibom (drugim zdravilom proti raku) ni več učinkovito ali imatiniba ne morete jemati.
Gastrointestinal stromal tumours
Gastrointestinalni stromalni tumorji (GIST)
Gastrointestinal stromal tumours (GIST)
Gastrointestinalni stromalni tumourji (GIST)
Gastrointestinal stromal tumours (GIST).
z gastrointestinalnimi stromalnimi tumorji (GIST).
Gastrointestinal studies
Študije vpliva na prebavila
Gastrointestinal symptoms (including diarrhoea, vomiting and nausea)
gastrointestinalni simptomi (vključno z diarejo, bruhanjem in navzeo)
Gastrointestinal symptoms (such as diarrhoea, vomiting, abdominal pain, nausea)
gastrointestinalni simptomi (na primer driska, bruhanje, bolečine v trebuhu, navzea)
Gastrointestinal symptoms could occur.
Lahko se pojavijo prebavne motnje.
gastrointestinal symptoms including nausea, vomiting, diarrhoea and abdominal pain
prebavni simptomi, vključno s siljenjem na bruhanje, bruhanjem, drisko in bolečinami v trebuhu,
Gastrointestinal symptoms including nausea, vomiting, diarrhoea and abdominal pain
prebavni simptomi, vključno z navzeo, bruhanjem, drisko in bolečino v trebuhu
Gastrointestinal symptoms such as nausea, vomiting, abdominal pain and stomach upset
Gastrointestinalni simptomi kot so siljenje na bruhanje, bruhanje, bolečina v trebuhu in razdražen želodec
Gastrointestinal symptoms, nausea
gastrointestinalni simptomi, navzea.
Gastrointestinal symptoms2 Very common
gastrointestinalni simptomi2 zelo pogosti
Gastrointestinal symptoms3, 5
prebavni simptomi3, 5
gastrointestinal symptoms6
prebavni simptomi6
Gastrointestinal symptomsi,§
dizurija poliurija*,f
Gastrointestinal symptomsi,§
dizurija* poliurija*,f
Gastrointestinal toxicity
Toksični učinki na prebavila
Gastrointestinal toxicity
Toksičnost za prebavila
Gastrointestinal toxicity was dose-limiting in a single ascending dose study.
V eni sami študiji naraščajočih odmerkov so bili gastrointestinalni toksični učinki tisti, ki so omejili odmerek.
Gastrointestinal tract
Gastrointestinalni trakt
gastrointestinal tract and not to
in ne zaradi spremenjene vrednosti
Gastrointestinal tract Nausea, vomiting, diarrhoea, abdominal pain, mouth ulceration
Prebavila navzea, bruhanje, driska, bolečine v trebuhu, razjede v ustih
gastrointestinal tumours, melanoma
gastrointestinalni tumorji, melanom
gastrointestinal ulcer
razjeda prebavil
Gastrointestinal ulcer
razjeda v prebavilih, vključno z ezofagealno razjedo
Gastrointestinal ulcer (not known)
razjeda v prebavilih (ni znana)
Gastrointestinal ulcer, including oesophageal ulcer
razjeda v prebavilih, vključno z ezofagealno razjedo
Gastrointestinal ulcera
nenormalnosti plodaa,b
Gastrointestinal ulceration has been reported in animals treated with corticosteroids and gastrointestinal ulceration may be exacerbated by steroids in animals given non-steroidal anti- inflammatory drugs and in animals with spinal cord trauma.
Pri živalih, ki so jih zdravili s kortikosteroidi, so poročali o razjedah v prebavilih, poleg tega pa steroidi lahko poslabšajo razjede v prebavilih pri živalih, ki se jih zdravi z nesteroidnimi protivnetnimi zdravili, in živalih s poškodbo hrbtenjače.
Gastrointestinal viral infection
Virusna okužba prebavil
Gastrointestinal: diarrhea, bloody stool, abdominal pain, nausea, or vomiting
prebavila: driska, krvavo blato, bolečine v trebuhu, slabost ali bruhanje;
Gastrooeosophageal reflux disease Abdominal tenderness
trdo blato, gastroezofagealni refluks, občutljivost trebuha,
Gastrooesophageal
gastroezofagealna
Gastrooesophageal reflux
gastroezofagealni refluks
Gastrooesophageal reflux disease
gastroezofagealna refluksna bolezen
Gastrooesophageal reflux disease (acid reflux)
gastroezofagealna refluksna bolezen (refluks kisline)
Gastrooesophageal reflux disease Proctalgia
dispepsija gastroezofagealna refluksna bolezen
gastrooesophageal reflux disease, pancreatitis
gastroezofagealna refluksna bolezen, pankreatitis
Gastrooesophageal reflux disease, salivary hypersecretion, hypoaesthesia oral
gastroezofagealna refluksna bolezen, čezmerno izločanje sline, hipestezija v ustih
Gather a clean empty cup to hold the pen while the medicine mixes, a clock/timer to measure the time while the medicine mixes and a container for pen disposal (these items are not provided in the pack).
Pripravite čist, prazen kozarec, v katerega boste odložili peresnik v času mešanja zdravila, uro/štoparico za merjenje časa mešanja zdravila in vsebnik, v katerega boste zavrgli peresnik (to troje ni priloženo zdravilu ).
Gather all materials needed for your injection.
Pripravite ves material, potreben za injiciranje.
Gather all supplies:
Zberite vse pripomočke:
Gather everything you need and lay it out:
Pripravite in pred sabo zložite vse potrebno:
Gather supplies for your injection on a clean, flat surface
Pripravite material za injiciranje na čisto in ravno površino
Gather the supplies for your injection:
Pripravite vse, kar boste potrebovali za injiciranje:
Gather together the necessary items
Pripravite vse, kar boste potrebovali
Gather your additional supplies and keep them within easy reach.
Pripravite dodatne potrebščine in jih imejte na dosegu roke.
Gatrointestinal disorders
Bolezni prebavil
Gaucher disease is a rare inherited disorder, in which people do not have enough of an enzyme called acid beta-glucosidase, which normally breaks down a fatty waste product called glucosylceramide.
Gaucherjeva bolezen je redka dedna napaka, pri kateri bolniku primanjkuje encima kisla beta- glukozidaza, ki razgrajuje maščobni odpadni produkt, imenovan glukozilceramid.
Gaucher disease is a rare inherited disorder, in which people do not have enough of an enzyme called glucocerebrosidase (also known as acid beta-glucosidase).
Gaucherjeva bolezen je redka prirojena bolezen, pri kateri bolnikom primanjkuje encima, imenovanega glukocerebrozidaza (tudi kisla beta-glukozidaza).
Gaucher disease is a rare recessively inherited metabolic disorder that results from a deficiency of the lysosomal enzyme acid -glucosidase.
Gaucherjeva bolezen je redka, recesivno podedovana presnovna motnja, ki je posledica pomanjkanja lizosomskega encima kisla -glukozidaza.
Gaucher disease;
Gaucherjeva bolezen;
Gaucher Registry to collect safety data according to an agreed protocol.
Group), v katerem se bodo zbirali podatki o varnosti v skladu z dogovorjenim protokolom.
Gauze Pad
Gaza Obliž
gauze pad adhesive bandage or plaster
gaza lepljivi povoj/obliž
Gauze pads
alkoholni robčki;
Gazyvaro + chlorambucil
zdravilo Gazyvaro + klorambucil
Gazyvaro 1,000 mg concentrate for solution for infusion Obinutuzumab
Gazyvaro 1000 mg koncentrat za raztopino za infundiranje obinutuzumab
Gazyvaro 1,000 mg concentrate for solution for infusion.
Gazyvaro 1000 mg koncentrat za raztopino za infundiranje
Gazyvaro contains the active substance obinutuzumab, which belongs to a group of medicines called “monoclonal antibodies”.
Zdravilo Gazyvaro vsebuje zdravilno učinkovino obinutuzumab, ki spada v skupino zdravil, imenovanih “monoklonska protitelesa”.
Gazyvaro has also been investigated in a study involving 321 patients with follicular lymphoma in whom treatment with rituximab had either not worked or had stopped working.
Zdravilo Gazyvaro je bilo raziskano tudi v študiji, v katero je bilo vključenih 321 bolnikov s folikularnim limfomom, pri katerih zdravljenje z rituksimabom ni učinkovalo ali je prenehalo učinkovati.
Gazyvaro has no or negligible influence on the ability to drive and use machines.
Zdravilo Gazyvaro ne vpliva ali pa ima zanemarljiv vpliv na sposobnost za vožnjo in upravljanje s stroji.
Gazyvaro in combination with bendamustine followed by Gazyvaro maintenance is indicated for the treatment of patients with follicular lymphoma (FL) who did not respond or who progressed during or up to 6 months after treatment with rituximab or a rituximab-containing regimen.
Zdravilo Gazyvaro je v kombinaciji z bendamustinom ter s poznejšo vzdrževalno uporabo zdravila Gazyvaro indicirano za zdravljenje bolnikov s folikularnim limfomom (FL), ki se na zdravljenje z rituksimabom ali shemo, ki je vključevala rituksimab, niso odzvali ali jim je bolezen med ali v 6 mesecih po takšnem zdravljenju napredovala.
Gazyvaro in combination with chlorambucil is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (CLL) and with comorbidities making them unsuitable for full-dose fludarabine based therapy (see section 5.1).
Zdravilo Gazyvaro je v kombinaciji s klorambucilom indicirano za zdravljenje odraslih bolnikov s predhodno nezdravljeno kronično limfocitno levkemijo (KLL), pri katerih zdravljenje s polnim odmerkom fludarabina zaradi pridruženih bolezni ni primerno (glejte poglavje 5.1).
Gazyvaro is used in patients who have had at least one treatment with a medicine called rituximab before and whose FL has come back or got worse after this treatment.
Zdravilo Gazyvaro uporabljamo pri bolnikih, ki so pred tem prejemali vsaj eno zdravljenje z zdravilom, imenovanim rituksimab, a se je folikularni limfom po tem zdravljenju pri njih ponovil ali poslabšal.
Gazyvaro is used in patients who have not had any treatment for CLL before and who have other illnesses which make it unlikely that they would be able to tolerate a full dose of a different medicine used to treat CLL called fludarabine.
Zdravilo Gazyvaro uporabljamo pri bolnikih, ki pred tem še niso prejemali nobenega zdravljenja za kronično limfocitno levkemijo in imajo pridružene bolezni, zaradi katerih je verjetno, da ne bi prenesli polnega odmerka drugega zdravila za zdravljenje kronične limfocitne levkemije, imenovanega fludarabin.
Gazyvaro was given by intravenous infusion as an absolute dose of 1,000 mg on Days 1, 8 and 15 of Cycle 1, on Day 1 of Cycles 2-6, and in patients who did not have disease progression, once every two months for two years or until disease progression (whichever occurs first).
Zdravilo Gazyvaro so dajali v intravenski infuziji v absolutnem odmerku 1000 mg 1., 8. in 15. dan ciklusa, 1. dan od 2. do 6. ciklusa ter, pri bolnikih, ki jim bolezen ni napredovala, enkrat na dva meseca v obdobju dveh let ali do napredovanja bolezni (kar od tega se je zgodilo prej).
Gazyvaro will be stored by the healthcare professionals at the hospital or clinic.
Zdravilo Gazyvaro bodo shranjevali zdravstveni delavci v bolnišnici ali ambulanti.
GBq/vial, (12 h CET)
GBq/viala, (12 h po srednjeevropskem času)
Gd-enhancing lesion on a follow-up scan taken at least three months after the initial scan.
Gd-stopnjevano poškodbo na naslednjem pregledu, ki mora biti opravljen vsaj tri mesece po prvem pregledu.
GDS01C/Protocol 009 evaluated immunogenicity of Gardasil 9 in girls 9 through 15 years of age (N=600; 300 receiving Gardasil 9 and 300 receiving qHPV vaccine).
GDS01C/Protokol 009 je ovrednotil imunogenost cepiva Gardasil 9 pri deklicah, starih od 9 do 15 let (N = 600; 300 jih je prejelo cepivo Gardasil 9 in 300 qHPV cepivo).
GDS07C/Protocol 020 evaluated immunogenicity of Gardasil 9 in men 16 through 26 years of age (N=500; 249 receiving Gardasil 9 and 251 receiving qHPV vaccine).
GDS07C/Protokol 020 je ovrednotil imunogenost cepiva Gardasil 9 pri moških, starih od 16 do 26 let (N = 500; 249 jih je prejelo cepivo Gardasil 9 in 251 qHPV cepivo).
ge is for single use only.
Ena napolnjena injekcijska brizga je samo za enkratno uporabo.
Gefitinib is extensively metabolised in humans.
Gefitinib se pri človeku izdatno presnovi.
gel capsule formulation)
(formulacija kapsule s trdim
gel for NexoBrid 2 g
gel za zdravilo NexoBrid 2 g
gel for NexoBrid 5 g
gel za zdravilo NexoBrid 5 g
Gel in metering pump.
gel v odmerni črpalki
Gel in sachet.
gel v vrečici
Gelatin
ovojnica kapsule
gelatin capsule filled with white to off-white powder.
Kapsula je napolnjena z belim do belkastim prahom.
Gelatin Mannitol
Želatina Manitol
gelatin titanium dioxide (E171) brilliant blue FCF (E133)
želatina titanov dioksid (E171) briljantno modro FCF (E133)
gelatin titanium dioxide (E171) indigo carmine (E132)
želatina titanov dioksid (E171) indigotin (E132)
gelatin titanium dioxide (E171) sunset yellow FCF (E110)
želatina titanov dioksid (E171) sončno rumena FCF (E110)
gelatin,
želatina
gelatin, mannitol (E421), aspartame (E951), sodium methyl parahydroxybenzoate (E219) and sodium propyl parahydroxybenzoate (E217).
Pomožne snovi so želatina, manitol (E421), aspartam (E951), natrijev metilparahidroksibenzoat (E219) in natrijev propilparahidroksibenzoat (E217).
Gelatin, Water,
magnezijev stearat
Geležinio Vilko g.
273 (67%)a
Gemcitabine
gemcitabin
Gemcitabine + cisplatin
Gemcitabin + Cisplatin
Gemfibrozil (medicine used to lower the level of fats [lipids] in the blood)
gemfibrozil (zdravilo za nižanje ravni maščob [lipidov] v krvi)
gemfibrozil (to lower high cholesterol level) angiotensin-convertising enzyme (ACE) inhibitors (to treat high blood pressure) cimetidine (to reduce stomach acid)
gemfibrozil (za zniževanje visoke ravni holesterola) zaviralci angiotenzinske konvertaze (zaviralci ACE) (za zdravljenje visokega krvnega tlaka) cimetidin (za zmanjševanje želodčne kisline)
gemfibrozil (used to lower cholesterol)
gemfibrozil (uporablja se za zniževanje holesterola)
gemfibrozil (used to lower cholesterol)
gemfibrozil (uporabljamo ga za zniževanje holesterola).
gemfibrozil (used to lower cholesterol) rifampicin (used to treat tuberculosis and other infections)
gemfibrozil (uporablja se za znižanje holesterola), rifampicin (uporablja se za zdravljenje tuberkuloze in drugih okužb).
gemfibrozil (used to lower cholesterol) rifampicin (used to treat tuberculosis and other infections)
gemfibrozil (uporablja se za zniževanje holesterola) rifampicin (uporablja se za zdravljenje tuberkuloze in drugih okužb)
gemfibrozil (used to lower cholesterol) rifampicin (used to treat tuberculosis and other infections)
gemfibrozil (uporablja se za zniževanje holesterola), rifampicin (uporablja se za zdravljenje tuberkuloze in drugih okužb).
gemfibrozil (used to lower cholesterol) rifampicin (used to treat tuberculosis and other infections)
gemfibrozil (uporabljamo ga za zniževanje holesterola). rifampicin (uporabljamo ga za zdravljenje tuberkuloze in drugih okužb).
gemfibrozil (used to lower cholesterol) rifampicin (used to treat tuberculosis and other infections)
gemfibrozil (uporabljamo ga za zniževanje vrednosti holesterola), rifampicin (uporabljamo ga za zdravljenje tuberkuloze in drugih okužb).
gemfibrozil (used to lower lipid levels); atazanavir, lopinavir, ritonavir, saquinavir, tipranavir (antiretrovirals used to treat HIV); rifampicin (antibiotic used to treat infections).
gemfibrozil (uporablja se za zniževanje ravni lipidov); atazanavir, lopinavir, ritonavir, sakvinavir, tipranavir (protiretrovirusna zdravila za zdravljenje okužbe z virusom HIV); rifampicin (antibiotik za zdravljenje okužb).
Gemfibrozil (used to treat high blood fats)
gemfibrozil (zdravilo za zdravljenje zvišane koncentracije maščob v krvi),
Gemfibrozil (used to treat high blood fats)
gemfibrozil (zdravilo za zdravljenje zvišane vrednosti maščob v krvi),
Gemfibrozil (used to treat high blood fats).
gemfibrozil (zdravilo za zdravljenje povišanih maščob v krvi),
Gemfibrozil (used to treat high blood fats).
gemfibrozil (zdravilo za zdravljenje zvišane vrednosti maščob v krvi),
Gemfibrozil 600 mg twice daily
600 mg dvakrat
gemfibrozil and fibrates (to lower high cholesterol level)
gemfibrozil in fibrati (za zniževanje visoke ravni holesterola)
gemfibrozil is necessary.
gemfibrozila ni
GEMINI II contained two cohorts of patients that received vedolizumab at Weeks 0 and 2: Cohort 1 patients were randomised to receive either vedolizumab 300 mg or placebo in a double-blind fashion, and Cohort 2 patients were treated with open-label vedolizumab 300 mg.
Študija GEMINI II je vključevala dve kohorti bolnikov, ki so vedolizumab prejeli na 0. in 2. teden: prva kohorta bolnikov je bila na dvojno slep način randomizirana bodisi na vedolizumab v odmerku 300 mg ali placebo, druga kohorta bolnikov pa se je z vedolizumabom v odmerku 300 mg zdravila na odprt način.
GEMINI II Study
Študija GEMINI II
GEMINI III Study
Študija GEMINI III
Gender
pol
Gender (pVTEp orthopaedic surgery)
Spol (pVTEp pri ortopedski operaciji)
Gender (SPAF, DVT/PE)
Spol (SPAF, GVT/PE)
Gender - Female (%)
Spol – ženski (%)
Gender / Weight
Spol/telesna masa
Gender 0.0397 1.7 times higher in females than males
Spol 0,0397 1,7-krat večji pri ženskah kot pri moških
Gender [female (n = 91), male (n = 132)] did not affect exposure of daratumumab to a clinically relevant degree.
Spol [ženske (n = 91), moški (n = 132)] ni v klinično pomembni meri vplival na izpostavljenost daratumumabu.
Gender and race had no clinically meaningful effect on the pharmacokinetics of dulaglutide.
Spol in rasa nista imela klinično pomembnega učinka na farmakokinetiko dulaglutida.
Gender and race have no clinically relevant influence on exenatide pharmacokinetics.
Spol in rasa nimata klinično značilnega vpliva na farmakokinetiko eksenatida.